Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration.
Many recent studies have emphasized the deleterious role of inflammation in CNS injury. Increases in free fatty acids, eicosanoids, and products of lipid peroxidation are known to occur in various conditions of acute and chronic CNS injury, including cerebral ischemia, traumatic brain injury, and Alzheimer's disease. Although an inflammatory response can be induced by many different means, phospholipases, such as cytosolic phospholipase A(2) (cPLA(2)), may play an important role in the production of inflammatory mediators and in the production of other potential second messengers. cPLA(2) hydrolyzes membrane phospholipids and its activity liberates free fatty acids leading directly to the production of eicosanoids. We investigated the cellular localization of cytosolic phospholipase A(2) in the CNS following: (1) focal and global cerebral ischemia, (2) facial nerve axotomy, (3) human cases of Alzheimer's disease, (4) transgenic mice overexpressing mutant superoxide dismutase, a mouse model of amyotrophic lateral sclerosis, and (5) transgenic mice overexpressing mutant amyloid precursor protein, which exhibits age-related amyloid deposition characteristic of Alzheimer's disease. We show that in every condition evaluated, cytosolic phospholipase A(2) is present in reactive glial cells within the precise region of neuron loss. In conditions where neurons did not degenerate or are protected from death, cytosolic phospholipase A(2) is not observed. Both astrocytes and microglial cells are immunoreactive for cytosolic phospholipase A(2) following injury, with astrocytes being the most consistent cell type expressing cytosolic phospholipase A(2). The presence of cytosolic phospholipase A(2) does not merely overlap with reactive astroglia, as reactive astrocytes were observed that did not exhibit cytosolic phospholipase A(2) immunoreactivity. In most conditions evaluated, inflammatory processes have been postulated to play a pivotal role and may even participate in neuronal cell death. These results suggest that cytosolic phospholipase A(2) may prove an attractive therapeutic target for neurodegeneration.
Graduate Program in Medical Neurobiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
D
D
Stephenson
K
K
Rash
B
B
Smalstig
E
E
Roberts
E
E
Johnstone
J
J
Sharp
J
J
Panetta
S
S
Little
R
R
Kramer
J
J
Clemens
D000544:Alzheimer Disease / Q000201:enzymology / Q000473:pathology; D016564:Amyloid beta-Protein Precursor / Q000235:genetics; D000818:Animals; D001253:Astrocytes / Q000201:enzymology / Q000473:pathology; D002545:Brain Ischemia / Q000201:enzymology / Q000473:pathology; D003600:Cytosol / Q000201:enzymology; D004195:Disease Models, Animal; D004790:Enzyme Induction; D020220:Facial Nerve Injuries / Q000201:enzymology; D005911:Gliosis / Q000201:enzymology* / Q000473:pathology; D006801:Humans; D007249:Inflammation; D007527:Isoenzymes / Q000096:biosynthesis* / Q000235:genetics; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D017628:Microglia / Q000201:enzymology / Q000473:pathology; D016472:Motor Neuron Disease / Q000201:enzymology / Q000473:pathology; D009410:Nerve Degeneration / Q000201:enzymology*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis* / Q000235:genetics; D009457:Neuroglia / Q000201:enzymology* / Q000473:pathology; D010741:Phospholipases A / Q000096:biosynthesis* / Q000235:genetics; D054467:Phospholipases A2; D016548:Prosencephalon / Q000098:blood supply; D051381:Rats; D011918:Rats, Inbred SHR; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D013482:Superoxide Dismutase / Q000235:genetics
D016564:Amyloid beta-Protein Precursor; D007527:Isoenzymes; D009419:Nerve Tissue Proteins; D013482:Superoxide Dismutase; D010741:Phospholipases A; D054467:Phospholipases A2